Search - tctmd.com

Displaying 21 - 40 of 99

Sort: Relevancy | Date

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2022

Shelley Wood

September 01, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Daily News

CASSISS: No Benefit of Stenting for Intracranial Stenosis

Todd Neale

August 12, 2022

News Daily News

RESCUE BT: IV Tirofiban No Help During Stroke Thrombectomy

Todd Neale

August 09, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Conference News TVT 2022

More Support for Single Antiplatelet Therapy After TAVI

Michael O'Riordan

June 10, 2022

News Daily News

Risk of Repeat Stroke Underrecognized in Nonstenotic Carotid Lesions

L.A. McKeown

May 06, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2022

Shelley Wood

May 02, 2022

News Daily News

Antithrombotics Not Worth the Risk During Endovascular Stroke Therapy

Todd Neale

March 07, 2022

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for October 2021

Shelley Wood

November 02, 2021

News Daily News

Predictors of AF May Help Guide Care After Stroke of Unknown Cause

Caitlin E. Cox

October 26, 2021

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Daily News

PAD Continues to Elude Clinicians, Despite Gains: AHA

L.A. McKeown

August 05, 2021

News Daily News

Antithrombotics No Help for Stable COVID-19 Outpatients: ACTIV-4b

Shelley Wood

June 22, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2021

Shelley Wood

May 31, 2021

News Conference News ACC 2021

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

L.A. McKeown

May 21, 2021

News Daily News

Short DAPT Bests Aspirin at Preventing Recurrent Events After Stroke, TIA

Yael L. Maxwell

April 29, 2021

News Daily News

Antiplatelets, Especially Cilostazol, Helpful in Moyamoya Arteriopathy

Michael O'Riordan

February 26, 2021

Advertisement

Only Half of Revascularized PAD Patients Receive GDMT

TCTMD’s Top 10 Most Popular Stories for August 2022

What’s Going to Be Hot at ESC 2022?

CASSISS: No Benefit of Stenting for Intracranial Stenosis

RESCUE BT: IV Tirofiban No Help During Stroke Thrombectomy

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

More Support for Single Antiplatelet Therapy After TAVI

Risk of Repeat Stroke Underrecognized in Nonstenotic Carotid Lesions

TCTMD’s Top 10 Most Popular Stories for April 2022

Antithrombotics Not Worth the Risk During Endovascular Stroke Therapy

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

TCTMD’s Top 10 Most Popular Stories for October 2021

Predictors of AF May Help Guide Care After Stroke of Unknown Cause

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

PAD Continues to Elude Clinicians, Despite Gains: AHA

Antithrombotics No Help for Stable COVID-19 Outpatients: ACTIV-4b

TCTMD’s Top 10 Most Popular Stories for May 2021

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

Short DAPT Bests Aspirin at Preventing Recurrent Events After Stroke, TIA

Antiplatelets, Especially Cilostazol, Helpful in Moyamoya Arteriopathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content